After rejection, FDA approves Telix’s Pixclara, the first FET-PET imaging drug for brain cancer Read more

GSK doubles down on Chimagen with $750M multiple myeloma wager Read more

Novo walks away from $285M pact to develop monthly GLP-1 obesity drug with Ascendis Read more

This event has passed.

2025 BioInfect Conference

February 5, 2025 @ 8:30 am

The agenda at BioInfect will focus on the issues surrounding the increasing threat of AMR and how it can be addressed.

Details

Date: February 5, 2025
Time:
8:30 am
Event Category: Conference
Website: https://bionow.co.uk/event/BIONOW195/2025-bioinfect-conference

Venue

The Spine – Liverpool
The Spine
Liverpool,